NPI registry status
Active
2026 NPPES data Pain Medicine Physician NPI 1316122922 MD
Verify on CMS → Michael Lott, MD
Pain Medicine Physician in Dallas, Georgia.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 1,006 in Pain Medicine Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
8K
Medicare Part D claims · 1K beneficiaries · Pain Medicine Physician avg: 2K
Generic prescribing
96%
generic claims · 4% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
92.9/100
▲ 9 pts above national avg 83.5 · Exceptional
Industry payments
$1.2K
64 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Michael Lott, MD reported a CMS MIPS final score of 92.9/100 - above the 83.5 national average - and filed 8,158 Medicare Part D claims in 2024.
- 92.9/100
- MIPS score · +9 vs avg
- 8K
- Part D claims, 2024
- 96%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Michael Lott, MD
Federal records show an active NPI with both Medicare prescribing volume and a measured CMS quality score — objective registry data, not patient reviews.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1316122922), first enumerated 01/02/2008.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 8,158 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
CMS quality reporting (MIPS)
Reported a CMS MIPS final score of 92.9/100 in the Quality Payment Program — a federal quality measure, not a patient review.
Source: CMS Quality Payment Program
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Hospital affiliations
1 CMS Care Compare hospital affiliation on record — practice footprint from the Doctors and Clinicians file.
Source: CMS Care Compare
- Reported
Industry payment transparency
$1.2K in reported industry payments (64 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1316122922 · Pain Medicine Physician
NPI-10 · ENUM-MID · TAX-NARROW · MIPS-ABOVE · RX-MID · BOOK-THIN · PHOTO-FINISH
- NPI-10 1316122922
- ENUM-MID 2008
- TAX-NARROW 1,006
- MIPS-ABOVE 92.9/100
- RX-MID 8,158
- BOOK-THIN 38 in Georgia
- PHOTO-FINISH Thomas Hansen · ±0.3
MIPS final-score neighbourhood
Same-specialty nationwide peers by CMS final score, not geographic proximity
- Thomas Hansen · …
Thomas Hansen
92.6 MIPS pts
- Lott · this prov…
Lott · this provider
92.9 MIPS pts
- Obinna Uzodinma …
Obinna Uzodinma
93.5 MIPS pts
- Peter Baek · near
Peter Baek
93.5 MIPS pts
- Essa Riaz · near
Essa Riaz
93.5 MIPS pts
What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).
Michael Lott, MD's MIPS score vs every measured U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.
93 ≥ 66th percentile 66% of 454,083 measured providers are in lower value bands
Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Michael Lott, MD sits
This provider among pain medicine physician peers
Across the 262 pain medicine physician providers who report both Medicare Part D prescribing and a MIPS quality score, Michael Lott, MD writes more Part D claims than 92% of them and scores higher on MIPS quality than 84% - placing this provider in the high-volume, high-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Each dot is one pain medicine physician peer from a representative sample of 60; the gold marker is Michael Lott, MD. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
Michael Lott, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Michael Lott, MD?
High performer (top quartile)Primary specialty
Pain Medicine Physician
Medicare Part D claims
8,158 290% vs specialty avg
MIPS final score
92.9/100 9.4 pts vs avg
Specialty distribution in Georgia
How Pain Medicine Physician compares to other specialties among Georgia providers
Medicare quality performance, MIPS
Michael Lott, MD's 2023 MIPS final score plotted against the Pain Medicine Physician national average
- MIPS Final Score
- 92.9/100
- vs 83.5 national avg · 2023 performance year
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1316122922 |
|---|---|
| Specialty | Pain Medicine Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 01/02/2008 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
92.9348
Final Score
Measured-score avg: 83.5
80.3814
Quality
100
Promoting Interoperability
Reporting: Alternative Payment Model
Hospital and facility affiliations
Facilities where Michael Lott, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Center For Spine Interventions, PC
Dallas, GA
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Michael Lott, MD. Source: openpaymentsdata.cms.gov.
Total received
$1.2K
Largest payer
Collegium Pharmaceutical, Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Generic-heavy
Michael Lott, MD - brand share 4.0%
Pain Medicine Physician average
4% brand-name claims vs 96% generic, on 8,158 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
8,158
Total Claims
$380K
Total Drug Cost
1,085
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 8,830.7
- Total Day Supply
- 251,481
- Brand vs Generic
- 4% brand / 96% generic
- Brand Drug Cost
- $232K
- Generic Drug Cost
- $147K
- Opioid Claims
- 4,101 (50.3% rate)
Patient Demographics
- Average Patient Age
- 71.1 years
- Avg HCC Risk Score
- 1.61
- Gender Split
- 66% female / 34% male
- Age Distribution
- <65: 198, 65-74: 507, 75-84: 318, 85+: 62
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Michael Lott, MD prescribes most
Top Medicare Part D drugs by claim count, 2024
- Oxycodone-Acetamin…
Oxycodone-Acetaminophen
1,491 claims
- Gabapentin
Gabapentin
1,120 claims
- Hydrocodone-Acetam…
Hydrocodone-Acetaminophen
982 claims
- Tramadol Hcl
Tramadol Hcl
628 claims
- Pregabalin 549
Pregabalin
549 claims
- Oxycodone Hcl 452
Oxycodone Hcl
452 claims
- Tizanidine Hcl 408
Tizanidine Hcl
408 claims
- Cyclobenzaprine Hcl 336
Cyclobenzaprine Hcl
336 claims
| Drug | Claims |
|---|---|
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 1,491 |
| Gabapentin | 1,120 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 982 |
| Tramadol Hcl | 628 |
| Pregabalin | 549 |
| Oxycodone Hcl | 452 |
| Tizanidine Hcl | 408 |
| Cyclobenzaprine Hcl | 336 |
| Morphine Sulfate Er Morphine Sulfate | 234 |
| Duloxetine Hcl | 205 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Pain Medicine Physician Overview
How Michael Lott, MD fits within the Pain Medicine Physician landscape nationally.
1,006
Pain Medicine Physician Providers in US
49
States with Pain Medicine Physician
2,094
Avg Claims per Provider
Michael Lott, MD's 8,158 claims are above the specialty average of 2,094.
Nationwide Pain Medicine Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Lott, both outside Georgia so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (92.9 here).
Same NPPES enumeration year (2008)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Pain Medicine Physician Providers in Georgia
Other clinicians with the same primary specialty enrolled in Georgia, drawn from the same CMS NPPES roster as Lott.
One of 38 Pain Medicine Physician providers enrolled in Georgia, 5 are shown here.
Dr. Subodh Agrawal
MD
Athens, GA
Jonathan Altman
Conyers, GA
Dr. Arnita Avery
DPM
Atlanta, GA
Dr. Gigi Bell-Wade
M.D.
Mableton, GA
Dr. Bradford Bootstaylor
M.D.
Atlanta, GA
Compare Pain Medicine Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Michael Lott, MD's specialty? ▼
Michael Lott, MD specializes in Pain Medicine Physician and practices in Dallas, Georgia. Credentials: MD.
How much does Michael Lott, MD prescribe under Medicare Part D? ▼
In 2024, Michael Lott, MD wrote 8,158 Medicare Part D claims totaling $380K in drug costs for 1,085 beneficiaries.
What is Michael Lott, MD's Medicare quality score? ▼
Michael Lott, MD has a CMS MIPS Final Score of 92.9/100 (Quality: 80.4). The average MIPS Final Score across the 454,083 clinicians with at least one published category score is 83.5; clinicians whose score CMS assigned without scoring any category are excluded from that average. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Michael Lott, MD located? ▼
Michael Lott, MD is located at 280 MERCHANTS SQ, Dallas, GA, 30132. Phone: (678) 813-2741.
What is Michael Lott, MD's NPI number? ▼
Michael Lott, MD's National Provider Identifier (NPI) is 1316122922, issued on 01/02/2008.
Does Michael Lott, MD prescribe more brand-name or generic drugs? ▼
Michael Lott, MD's prescribing is 4% brand-name and 96% generic drugs by claim count, with $232K in brand drug costs.
Does Michael Lott, MD prescribe opioids? ▼
Yes, Michael Lott, MD had 4,101 opioid claims in 2024 with an opioid prescribing rate of 50.3%.
How many Pain Medicine Physician providers are there in the US? ▼
There are 1,006 Pain Medicine Physician providers across 49 states in the US. The average Pain Medicine Physician provider writes 2,094 Medicare Part D claims per year.
What drugs does Michael Lott, MD prescribe most often? ▼
Based on 2024 Medicare Part D data, Michael Lott, MD's most frequently prescribed drugs include Oxycodone-Acetaminophen, Gabapentin, Hydrocodone-Acetaminophen. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Michael Lott, MD accept Medicare? ▼
Michael Lott, MD appears in CMS Medicare data with 8,158 Part D claims and 1,085 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Michael Lott, MD's credentials? ▼
Michael Lott, MD's NPI is 1316122922 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.